Walleye Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Walleye Trading’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$4K	–	5868
2016 Q2	$4K	Buy	+500	New	+$3.75K	﹤0.01%	5053
2015 Q3	–	Sell	-2,263	Closed	-$19K	–	5865
2015 Q2	$19K	Buy	+2,263	New	+$20K	﹤0.01%	4016
2014 Q3	–	Sell	-12,864	Closed	-$75.1K	–	4517
2014 Q2	$82	Buy	12,864 +7,500	+140%	+$51.6K	﹤0.01%	2607
2014 Q1	$43	Buy	5,364 +2,833	+112%	+$22.1K	﹤0.01%	2790
2013 Q4	$17K	Sell	2,531 -59	-2%	-$319	﹤0.01%	3206
2013 Q3	$48K	Buy	2,590 +2,517	+3,448%	+$48.9K	﹤0.01%	2281
2013 Q2	$1K	Buy	+73	New	+$1.29K	﹤0.01%	2913

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Walleye Trading's ARIA Position: Q3 2016 in Review

Walleye Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 500 shares — an estimated $4K sold.

Walleye Trading first reported a position in ARIA in Q2 2013 and held it in 7 quarters. The position peaked at $48K in Q3 2013. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Walleye Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Walleye Trading sold 500 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $4K.
Walleye Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
Walleye Trading's Ariad Pharmaceuticals Inc position peaked at $48K in Q3 2013.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.